Evidence map›Paper›PMID 34680178›Full record

ArticleBiomolecules2021

Higher

Chiara Mulè, Raffaele Ciampi, Teresa Ramone, Alessandro Prete, Antonio Matrone, Virginia Cappagli, Liborio Torregrossa, Fulvio Basolo, Rossella Elisei, Cristina Romei

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chiara MulèEndocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.
Raffaele CiampiEndocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.
Teresa RamoneEndocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.
Alessandro PreteEndocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.
Antonio MatroneEndocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.ORCID 0000-0003-4263-4717
Virginia CappagliEndocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.ORCID 0000-0003-0726-8125
Liborio TorregrossaDepartment of Surgical, Medical, Molecular Pathology, University of Pisa, 56124 Pisa, Italy.
Fulvio BasoloDepartment of Surgical, Medical, Molecular Pathology, University of Pisa, 56124 Pisa, Italy.
Rossella EliseiEndocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.ORCID 0000-0002-5333-9257
Cristina RomeiEndocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.
University of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was designed to investigate whether

Indexed as

Carcinoma, NeuroendocrineFemaleGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingHumansMaleMutationProtein IsoformsProto-Oncogene Proteins c-retras ProteinsRNA, MessengerThyroid NeoplasmsProtein IsoformsProto-Oncogene Proteins c-retras ProteinsRET protein, humanRNA, Messengermedullary thyroid carcinomamRNA expressionRASRET

Identifiers

PMID34680178
PMCPMC8533768
OpenAlexW3206375641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.